应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02251 鹰瞳科技-B
未开盘 04-16 16:08:30
10.660
-0.320
-2.91%
最高
10.860
最低
10.200
成交量
5.65万
今开
10.300
昨收
10.980
日振幅
6.01%
总市值
11.03亿
流通市值
5.65亿
总股本
1.03亿
成交额
58.42万
换手率
0.11%
流通股本
5,301万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
鹰瞳科技-B盘中异动 早盘快速下挫6.38%
市场透视 · 04-16 02:01
鹰瞳科技-B盘中异动 早盘快速下挫6.38%
鹰瞳科技-B盘中异动 急速跳水5.06%
市场透视 · 03-11
鹰瞳科技-B盘中异动 急速跳水5.06%
【公司盈警】鹰瞳科技(02251)料去年股东应占亏损扩大至最多2.5亿元人民币
金吾财讯 · 03-11
【公司盈警】鹰瞳科技(02251)料去年股东应占亏损扩大至最多2.5亿元人民币
鹰瞳科技-B03月10日遭主力抛售26万元
市场透视 · 03-10
鹰瞳科技-B03月10日遭主力抛售26万元
鹰瞳科技-B股价重挫10.01% 市值跌7152.25万港元
市场透视 · 03-10
鹰瞳科技-B股价重挫10.01% 市值跌7152.25万港元
美的集团：万东医疗属于其他创新业务，致力于医学影像技术创新并为临床提供优质医学影像产品和服务
证券之星 · 03-07
美的集团：万东医疗属于其他创新业务，致力于医学影像技术创新并为临床提供优质医学影像产品和服务
鹰瞳科技-B盘中异动 股价大涨6.22%报14.000港元
市场透视 · 03-03
鹰瞳科技-B盘中异动 股价大涨6.22%报14.000港元
战略布局再下一城，晶科电子(02251)进入价值加速成长期
智通财经 · 03-03
战略布局再下一城，晶科电子(02251)进入价值加速成长期
鹰瞳科技-B盘中异动 股价大涨5.01%报13.840港元
市场透视 · 02-28
鹰瞳科技-B盘中异动 股价大涨5.01%报13.840港元
蹭流量讲新故事？科技基金重仓股 频频破圈医疗赛道
券商中国 · 02-19
蹭流量讲新故事？科技基金重仓股 频频破圈医疗赛道
【讯飞医疗：与一脉阳光达成战略合作】讯飞医疗(02506.HK)宣布，与一脉阳光(02522.HK)于近日订立战略合作协议。根据协议，双方拟在业务市场开发、优势产品和业务模式的深度合作、创新的智慧医疗业务投资模式设计、医疗垂类认知大模型及医学影像AI诊断大模型的合作研发及共同探索智能化的健康管理等领域开展合作。
金融界 · 02-19
【讯飞医疗：与一脉阳光达成战略合作】讯飞医疗(02506.HK)宣布，与一脉阳光(02522.HK)于近日订立战略合作协议。根据协议，双方拟在业务市场开发、优势产品和业务模式的深度合作、创新的智慧医疗业务投资模式设计、医疗垂类认知大模型及医学影像AI诊断大模型的合作研发及共同探索智能化的健康管理等领域开展合作。
鹰瞳科技-B盘中异动 早盘股价大涨6.28%报13.200港元
市场透视 · 02-19
鹰瞳科技-B盘中异动 早盘股价大涨6.28%报13.200港元
鹰瞳科技-B盘中异动 股价大跌5.47%报12.800港元
市场透视 · 02-18
鹰瞳科技-B盘中异动 股价大跌5.47%报12.800港元
鹰瞳科技-B盘中异动 早盘股价大跌6.63%
市场透视 · 02-17
鹰瞳科技-B盘中异动 早盘股价大跌6.63%
异动解读 | 鹰瞳科技-B盘中大涨6.5% "AI+医疗"概念发酵
异动解读 · 02-14
异动解读 | 鹰瞳科技-B盘中大涨6.5% "AI+医疗"概念发酵
鹰瞳科技-B盘中异动 早盘股价大涨6.50%报12.780港元
市场透视 · 02-14
鹰瞳科技-B盘中异动 早盘股价大涨6.50%报12.780港元
“AI+医疗”概念火热并获多方看好 相关股份集体走高 医渡科技(02158)涨10.38%
金吾财讯 · 02-14
“AI+医疗”概念火热并获多方看好 相关股份集体走高 医渡科技(02158)涨10.38%
【券商聚焦】交银国际指AI技术驱动医药板块新机遇 关注AI相关的创新和估值修复机会
金吾财讯 · 02-14
【券商聚焦】交银国际指AI技术驱动医药板块新机遇 关注AI相关的创新和估值修复机会
加载更多
公司概况
公司名称：
鹰瞳科技-B
所属市场：
SEHK
上市日期：
--
主营业务：
北京鹰瞳科技发展股份有限公司是一家中国公司。该公司的主营业务是提供基于人工智能的视网膜早期检测、诊断和健康风险评估解决方案。该公司主要产品为Airdoc-AIFUNDUS 1.0。该公司的产品可用于青光眼、白内障、ICVD和ASCVD、妊娠糖尿病视网膜病变、妊娠高血压视网膜病变等疾病的诊断 此外，该公司还开发了一系列其他医疗器械软件 (SaMD) 和健康风险评估解决方案，以满足包括医院、社区诊所、健康检查中心、保险公司在内的全人群的各种医疗保健需求。
发行价格：
--
{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":10.66,"timestamp":1744790910031,"preClose":10.98,"halted":0,"volume":56500,"delay":0,"floatShares":53005000,"shares":103494013,"eps":-2.655967328852184,"marketStatus":"未开盘","change":-0.32,"latestTime":"04-16 16:08:30","open":10.3,"high":10.86,"low":10.2,"amount":584224,"amplitude":0.060109,"askPrice":10.7,"askSize":1000,"bidPrice":10.28,"bidSize":1400,"shortable":0,"etf":0,"ttmEps":-2.655967328852184,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744853400000},"marketStatusCode":0,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":10.98,"openAndCloseTimeList":[[1744767000000,1744776000000],[1744779600000,1744790400000]],"volumeRatio":0.47561484801801013,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"2527601283","title":"鹰瞳科技-B盘中异动 早盘快速下挫6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527601283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527601283?lang=zh_cn&edition=full","pubTime":"2025-04-16 10:01","pubTimestamp":1744768862,"startTime":"0","endTime":"0","summary":"2025年04月16日早盘10时01分，鹰瞳科技-B股票出现异动，股价快速下挫6.38%。截至发稿，该股报10.280港元/股，成交量700股，换手率0.00%，振幅0.18%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.09%。其相关个股中，紫元元、启明医疗-B、GUANZE MEDICAL涨幅较大，振幅较大的相关个股有巨星医疗控股、紫元元、堃博医疗-B，振幅分别为13.10%、8.48%、6.86%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416100102a6bbeedf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416100102a6bbeedf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2518758431","title":"鹰瞳科技-B盘中异动 急速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518758431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518758431?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:45","pubTimestamp":1741661133,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘10时45分，鹰瞳科技-B股票出现波动，股价大幅跳水5.06%。截至发稿，该股报13.500港元/股，成交量6200股，换手率0.01%，振幅3.52%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.06%。其相关个股中，中国卫生集团、康沣生物-B、健世科技-B涨幅较大，振幅较大的相关个股有心玮医疗-B、先瑞达医疗-B、巨星医疗控股，振幅分别为7.93%、7.80%、7.14%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110453398a344cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110453398a344cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2518369097","title":"【公司盈警】鹰瞳科技(02251)料去年股东应占亏损扩大至最多2.5亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2518369097","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518369097?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:04","pubTimestamp":1741655094,"startTime":"0","endTime":"0","summary":"金吾财讯 | 鹰瞳科技 发盈警，预期于截至2024年12月31日止年度录得未经审核亏损介乎人民币2.5亿元至人民币2.7亿元，及于截至2024年12月31日止年度录得母公司拥有人应占未经审核亏损介乎人民币2.4亿元至人民币2.5亿元。据公告指，亏损扩大主要是由于监管架构变动影响集团的激光近视治疗AI。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ZjI2Mjk2NDJlMTg0ZTY2MjVhYzY3MmYxYmE2MzM4MDk2MjYyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjI2Mjk2NDJlMTg0ZTY2MjVhYzY3MmYxYmE2MzM4MDk2MjYyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954739","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2518163219","title":"鹰瞳科技-B03月10日遭主力抛售26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518163219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518163219?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:16","pubTimestamp":1741594611,"startTime":"0","endTime":"0","summary":"03月10日, 鹰瞳科技-B股价跌5.07%，报收14.22元，成交金额336万元，换手率0.45%，振幅12.95%，量比0.63。鹰瞳科技-B今日主力资金净流出26万元，上一交易日主力净流出36万元。该股近5个交易日上涨0.71%，主力资金累计净流入29万元；近20日主力资金累计净流入367万元，其中净流入天数为4日。该股主力净额占比0.03%，港股市场排名2460/2655。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170525abf29608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170525abf29608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2518254091","title":"鹰瞳科技-B股价重挫10.01% 市值跌7152.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518254091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518254091?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:26","pubTimestamp":1741573564,"startTime":"0","endTime":"0","summary":"2025年03月10日早盘10时26分，鹰瞳科技-B股票出现异动，股价大幅跳水10.01%。截至发稿，该股报13.480港元/股，成交量7.09万股，换手率0.13%，振幅10.95%。资金方面，该股资金流入5.078万港元，流出89.7904万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.03%。其相关个股中，康沣生物-B、微创机器人-B、心玮医疗-B涨幅较大，振幅较大的相关个股有高视医疗、心泰医疗、鹰瞳科技-B，振幅分别为20.77%、14.21%、10.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310102604a269361e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310102604a269361e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2517101418","title":"美的集团：万东医疗属于其他创新业务，致力于医学影像技术创新并为临床提供优质医学影像产品和服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2517101418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517101418?lang=zh_cn&edition=full","pubTime":"2025-03-07 17:36","pubTimestamp":1741340215,"startTime":"0","endTime":"0","summary":"美的集团中央研究院与和佑医院合作大影像多模态融合诊断技术：快速高质量 3D 磁共振：脑 PET-CT 关键技术均为贵司控股的万东医疗业务，涉及同业竞争，侵害了其他股东的利益，请问贵司如何处理？其中，万东医疗属于其他创新业务，致力于医学影像技术创新并为临床提供优质医学影像产品和服务。美的集团中央研究院是公司最高技术研究机构，聚焦中长期共性技术、前瞻技术研究及颠覆性产品平台创新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700030389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245094.SGD","IE0031814852.USD","LU0509642566.USD","LU2097828474.EUR","LU0898667661.SGD","BK0012","00300","LU0231483743.USD","IE0009570106.USD","LU2097828631.EUR","IE00B8L5B284.USD","BK0026","02251","BK0187","LU0862451753.SGD","LU2495084118.USD","LU1997244956.HKD","BK0196","LU0396098781.USD","LU0955623706.USD","LU2148510915.USD","LU1064131003.USD","LU0831103253.SGD","LU2476274308.USD","LU0890818403.SGD","LU1655091616.SGD","LU1064130708.USD","LU1366334578.USD","BK0146","IE00B031J352.USD","LU1580142542.USD","LU2097828714.EUR","IE00BZ08YS42.EUR","LU0572939691.SGD","LU1366334651.USD","BK0224","IE00B8HQ1Z84.USD","LU1048484197.HKD","IE0008368411.USD","IE00B29SXG58.USD","600055","BK0061","LU0955648018.USD","LU2778985437.USD","LU0955669360.SGD","LU1820825898.SGD","LU0828238088.HKD","IE0003851619.USD","LU1568876335.HKD","000333"],"gpt_icon":0},{"id":"2516505870","title":"鹰瞳科技-B盘中异动 股价大涨6.22%报14.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516505870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516505870?lang=zh_cn&edition=full","pubTime":"2025-03-03 15:15","pubTimestamp":1740986125,"startTime":"0","endTime":"0","summary":"2025年03月03日下午盘15时15分，鹰瞳科技-B股票出现波动，股价急速拉升6.22%。截至发稿，该股报14.000港元/股，成交量12.83万股，换手率0.24%，振幅7.59%。资金方面，该股资金流入124.33万港元，流出47.7434万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.28%。其相关个股中，百心安-B、鹰瞳科技-B、巨星医疗控股涨幅较大，振幅较大的相关个股有心通医疗-B、HKE HOLDINGS、先健科技，振幅分别为10.99%、10.69%、9.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303151525abe597db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303151525abe597db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2516957813","title":"战略布局再下一城，晶科电子(02251)进入价值加速成长期","url":"https://stock-news.laohu8.com/highlight/detail?id=2516957813","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516957813?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:52","pubTimestamp":1740970326,"startTime":"0","endTime":"0","summary":"2025年2月7日，广州市2025年一季度重大项目开工活动在广州南沙区万顷沙隆重举行。在最新的业绩预告，晶科电子在财报中指出，凭借全球协同化发展的核心竞争力打造，公司预计在2024年度实现归母净利润不低于9300万元，较2023年度增长不少于40%;实现经调整归母净利润不低于1.3亿元，较2023年度增长不少于70%。由此，不难预计，伴随着公司业绩增长活力的不断释放，晶科电子后续将具备充足的动能迈入价值加速成长期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02551","BK1116","02251"],"gpt_icon":0},{"id":"2514676583","title":"鹰瞳科技-B盘中异动 股价大涨5.01%报13.840港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514676583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514676583?lang=zh_cn&edition=full","pubTime":"2025-02-28 10:44","pubTimestamp":1740710694,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘10时44分，鹰瞳科技-B股票出现异动，股价大幅拉升5.01%。截至发稿，该股报13.840港元/股，成交量9.65万股，换手率0.18%，振幅7.28%。资金方面，该股资金流入72.494万港元，流出33.1272万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.44%。其相关个股中，鹰瞳科技-B、紫元元、微泰医疗-B涨幅较大，振幅较大的相关个股有百心安-B、微创机器人-B、佳兆业健康，振幅分别为11.27%、11.18%、10.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228104454a2572b89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228104454a2572b89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2512567114","title":"蹭流量讲新故事？科技基金重仓股 频频破圈医疗赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2512567114","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512567114?lang=zh_cn&edition=full","pubTime":"2025-02-20 07:27","pubTimestamp":1740007630,"startTime":"0","endTime":"0","summary":"【蹭流量讲新故事？科技基金重仓股 频频破圈医疗赛道】记者注意到，科技公司跨界布局医疗赛道正形成一种风潮，以游戏机业务起家的日本索尼已在手术机器人、医学影像学等赛道建立庞大的医疗业务，甚至成为公募医疗基金重仓股的大股东。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502203324010238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0823397103.USD","02251","LU1044876610.USD","LU0048388663.USD","IE0003795394.USD","LU0463099449.HKD","LU0244354667.USD","LU1642822792.SGD","TCEHY","LU1048596156.SGD","YANG","LU0048580855.USD","LU0509642566.USD","03086","LU1251922891.USD","LU0700851271.USD","LU1242518931.SGD","SG9999002828.SGD","LU0203345920.USD","LU0132412106.USD","LU1323998911.USD","LU1733274390.USD","LU1810669033.SGD","BK1589","LU0588545490.SGD","SG9999001093.SGD","80700","IE00BF5LJ272.USD","LU0348788117.USD","LU0786609619.USD","00700","SG9999018865.SGD","BK1517","HTCD.SI","HSTECH","LU0605514214.HKD","TTTN","LU0543330566.HKD","LU1328277881.USD","02192","HSCEI","LU0348825331.USD","LU2251237488.HKD","LU0882747503.HKD","SG9999001051.SGD","LU0345776255.USD","01357","LU0823426308.USD","LU0708995153.HKD"],"gpt_icon":1},{"id":"2512317444","title":"【讯飞医疗：与一脉阳光达成战略合作】讯飞医疗(02506.HK)宣布，与一脉阳光(02522.HK)于近日订立战略合作协议。根据协议，双方拟在业务市场开发、优势产品和业务模式的深度合作、创新的智慧医疗业务投资模式设计、医疗垂类认知大模型及医学影像AI诊断大模型的合作研发及共同探索智能化的健康管理等领域开展合作。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512317444","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512317444?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:09","pubTimestamp":1739959747,"startTime":"0","endTime":"0","summary":"讯飞医疗(02506.HK)宣布，与一脉阳光(02522.HK)于近日订立战略合作协议。根据协议，双方拟在业务市场开发、优势产品和业务模式的深度合作、创新的智慧医疗业务投资模式设计、医疗垂类认知大模型及医学影像AI诊断大模型的合作研发及共同探索智能化的健康管理等领域开展合作。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19180948262675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1189","02506","02522","02251","BK1219","159891"],"gpt_icon":0},{"id":"2512432491","title":"鹰瞳科技-B盘中异动 早盘股价大涨6.28%报13.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512432491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512432491?lang=zh_cn&edition=full","pubTime":"2025-02-19 09:51","pubTimestamp":1739929885,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘09时51分，鹰瞳科技-B股票出现波动，股价急速上涨6.28%。截至发稿，该股报13.200港元/股，成交量7.57万股，换手率0.14%，振幅5.80%。资金方面，该股资金流入48.0664万港元，流出27.118万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.12%。其相关个股中，鹰瞳科技-B、紫元元、先瑞达医疗-B涨幅较大，振幅较大的相关个股有智云健康、微创机器人-B、微创脑科学，振幅分别为7.22%、6.91%、5.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219095125abd4406f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219095125abd4406f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2512894871","title":"鹰瞳科技-B盘中异动 股价大跌5.47%报12.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512894871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512894871?lang=zh_cn&edition=full","pubTime":"2025-02-18 13:55","pubTimestamp":1739858158,"startTime":"0","endTime":"0","summary":"2025年02月18日下午盘13时55分，鹰瞳科技-B股票出现异动，股价大幅跳水5.47%。截至发稿，该股报12.800港元/股，成交量51.11万股，换手率0.96%，振幅6.50%。资金方面，该股资金流入309.993万港元，流出359.321万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.04%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021813555896271442&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021813555896271442&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2512967229","title":"鹰瞳科技-B盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512967229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512967229?lang=zh_cn&edition=full","pubTime":"2025-02-17 10:12","pubTimestamp":1739758361,"startTime":"0","endTime":"0","summary":"2025年02月17日早盘10时12分，鹰瞳科技-B股票出现波动，股价急速下挫6.63%。截至发稿，该股报13.520港元/股，成交量16.89万股，换手率0.32%，振幅10.08%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.39%。其相关个股中，紫元元、心泰医疗、加和国际控股涨幅较大，振幅较大的相关个股有微创机器人-B、智云健康、鹰瞳科技-B，振幅分别为12.62%、8.82%、8.15%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021710124198880b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021710124198880b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"1176054972","title":"异动解读 | 鹰瞳科技-B盘中大涨6.5% \"AI+医疗\"概念发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1176054972","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176054972?lang=zh_cn&edition=full","pubTime":"2025-02-14 10:30","pubTimestamp":1739500251,"startTime":"0","endTime":"0","summary":"\"AI+医疗\"概念再度引发市场热议,鹰瞳科技-B今日盘中大涨6.5%,其他相关个股亦纷纷上扬。\n业界看好\"AI+医疗\"前景,谷歌DeepSeek模型在疾病诊断、药物研发领域有望提高效率,获多家医药企业青睐。有分析指出,AI技术在医疗健康领域应用渗透率仍较低,未来存在广阔增长空间。\n作为医疗AI公司,鹰瞳科技深耕眼科AI辅助诊疗等业务。随着\"AI+医疗\"产业红利释放,未来公司或将从中获益,因而备受资金热捧。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 鹰瞳科技-B盘中大涨6.5% \"AI+医疗\"概念发酵","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02251"],"gpt_icon":0},{"id":"2511689283","title":"鹰瞳科技-B盘中异动 早盘股价大涨6.50%报12.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511689283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511689283?lang=zh_cn&edition=full","pubTime":"2025-02-14 10:28","pubTimestamp":1739500121,"startTime":"0","endTime":"0","summary":"2025年02月14日早盘10时28分，鹰瞳科技-B股票出现波动，股价急速上涨6.50%。截至发稿，该股报12.780港元/股，成交量1.88万股，换手率0.04%，振幅6.33%。资金方面，该股资金流入8.8698万港元，流出10.224万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.28%。其相关个股中，微创机器人-B、微创脑科学、心通医疗-B涨幅较大，振幅较大的相关个股有心通医疗-B、智云健康、心玮医疗-B，振幅分别为8.97%、8.86%、8.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141028419884d11a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141028419884d11a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2511686533","title":"“AI+医疗”概念火热并获多方看好 相关股份集体走高 医渡科技(02158)涨10.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511686533","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511686533?lang=zh_cn&edition=full","pubTime":"2025-02-14 09:52","pubTimestamp":1739497955,"startTime":"0","endTime":"0","summary":"金吾财讯 | “AI+医疗”概念火热，医渡科技 涨10.38%，信达生物涨5.3%，晶泰控股涨3.97%，讯飞医疗科技涨3.07%，鹰瞳科技跟涨。交银国际表示，AI大模型赋能数字医疗服务公司，在疾病诊断/检测方面潜力显着。另外，高盛此前在2025年国际消费类电子产品展览会数字医疗健康专场中，即点明“AI+医疗”将成为该行业吸引全球资金最核心的投资主题。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953143","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1518","BK1161","BK1189","LU2328871848.SGD","01801","BK1583","159891","BK1589","02228","LU2488822045.USD","LU1969619763.USD","02158","02506","02251"],"gpt_icon":0},{"id":"2511500266","title":"【券商聚焦】交银国际指AI技术驱动医药板块新机遇 关注AI相关的创新和估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2511500266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511500266?lang=zh_cn&edition=full","pubTime":"2025-02-14 09:12","pubTimestamp":1739495546,"startTime":"0","endTime":"0","summary":"国家医保局发文提及江西省结算改革成果，医药供货企业回款周期已由半年减至30天。该行指，AI大模型赋能数字医疗服务公司，在疾病诊断/检测方面潜力显着。同时，能助力医药研发提高效率、优化药物设计，利好CRO和创新药企。结合后续财政和医保/商保利好政策有望继续出台、整体板块估值仍处历史底部，该行认为板块仍有较大修复空间。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK1141","IE00B5MMRT66.SGD","LU0348784397.USD","01952","BK1518","02096","01177","02228","09926","BK1589","02506","BK1147","BK1191","LU2488822045.USD","01801","BK1189","BK1574","LU0348783233.USD","BK1521","LU1794554557.SGD","03329","IE00BPRC5H50.USD","BK1161","162414","BK1583","LU1720050803.USD","LU2328871848.SGD","02158","BK1515","09939","03692","LU0417516571.SGD","02251","IE00B543WZ88.USD","159938"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0019},{"period":"1month","weight":-0.2375},{"period":"3month","weight":0.0038},{"period":"6month","weight":-0.0396},{"period":"1year","weight":-0.3014},{"period":"ytd","weight":-0.1347}],"compareEarnings":[{"period":"1week","weight":0.0391},{"period":"1month","weight":-0.1279},{"period":"3month","weight":0.0786},{"period":"6month","weight":0.0122},{"period":"1year","weight":0.2959},{"period":"ytd","weight":0.0497}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京鹰瞳科技发展股份有限公司是一家中国公司。该公司的主营业务是提供基于人工智能的视网膜早期检测、诊断和健康风险评估解决方案。该公司主要产品为Airdoc-AIFUNDUS 1.0。该公司的产品可用于青光眼、白内障、ICVD和ASCVD、妊娠糖尿病视网膜病变、妊娠高血压视网膜病变等疾病的诊断 此外，该公司还开发了一系列其他医疗器械软件 (SaMD) 和健康风险评估解决方案，以满足包括医院、社区诊所、健康检查中心、保险公司在内的全人群的各种医疗保健需求。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.090947},{"month":2,"riseRate":0.75,"avgChangeRate":0.143482},{"month":3,"riseRate":0.25,"avgChangeRate":-0.077232},{"month":4,"riseRate":0,"avgChangeRate":-0.080451},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.112317},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.004367},{"month":7,"riseRate":0,"avgChangeRate":-0.070414},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.035493},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.077379},{"month":10,"riseRate":0.333333,"avgChangeRate":0.00463},{"month":11,"riseRate":1,"avgChangeRate":0.176261},{"month":12,"riseRate":0.5,"avgChangeRate":-0.105305}],"exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}